Beth J Hoffman

Neuro Eli Lilly & Co 
"Beth Hoffman"
Mean distance: (not calculated yet)


Sign in to add trainee
Hong Yu research scientist 2001-2004 Eli Lilly & Co
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Van Goor F, Yu H, Burton B, et al. (2014) Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 13: 29-36
Ren HY, Grove DE, De La Rosa O, et al. (2013) VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1. Molecular Biology of the Cell. 24: 3016-24
Yu H, Burton B, Huang CJ, et al. (2012) Ivacaftor potentiation of multiple CFTR channels with gating mutations. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 11: 237-45
Cheng Y, Albrecht BK, Brown J, et al. (2008) Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists. Journal of Medicinal Chemistry. 51: 5019-34
Walter MW, Hoffman BJ, Gordon K, et al. (2007) Discovery and SAR studies of novel GlyT1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17: 5233-8
Johnson KW, Clemens-Smith A, Nomikos G, et al. (2003) In vivo characterization of changes in glycine levels induced by GlyT1 inhibitors. Annals of the New York Academy of Sciences. 1003: 412-4
Cohen ML, Galbreath EJ, Schenck KW, et al. (2002) Lack of sumatriptan-induced aortic contraction or relaxation: 5-HT1B receptor protein detected in endothelium and smooth muscle of vasa vasorum but not aorta. Receptors & Channels. 8: 71-8
See more...